Patent Number: 6,165,507

Title: Slow-release pharmaceutical formulations containing mizolastine

Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.

Inventors: Chariot; Maryvonne (La Ville du Bois, FR), Lewis; Gareth (Dourdan, FR), Montel; Jean (Chatou, FR)

Assignee: Synthelabo

International Classification: A61K 9/20 (20060101); A61K 9/28 (20060101); A61K 31/506 (20060101); A61K 009/22 (); A61K 009/36 (); A61K 009/14 (); A61K 031/505 ()

Expiration Date: 12/26/2017